{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,13]],"date-time":"2026-06-13T05:43:49Z","timestamp":1781329429870,"version":"3.54.1"},"reference-count":90,"publisher":"MDPI AG","issue":"18","license":[{"start":{"date-parts":[[2019,9,5]],"date-time":"2019-09-05T00:00:00Z","timestamp":1567641600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Molecules"],"abstract":"<jats:p>Chronic kidney disease (CKD) is problem that has become one of the major issues affecting public health. Extensive clinical data suggests that the prevalence of hyperlipidemia in CKD patients is significantly higher than in the general population. Lipid metabolism disorders can damage the renal parenchyma and promote the occurrence of cardiovascular disease (CVD). Cyanate is a uremic toxin that has attracted widespread attention in recent years. Usually, 0.8% of the molar concentration of urea is converted into cyanate, while myeloperoxidase (MPO) catalyzes the oxidation of thiocyanate to produce cyanate at the site of inflammation during smoking, inflammation, or exposure to environmental pollution. One of the important physiological functions of cyanate is protein carbonylation, a non-enzymatic post-translational protein modification. Carbamylation reactions on proteins are capable of irreversibly changing protein structure and function, resulting in pathologic molecular and cellular responses. In addition, recent studies have shown that cyanate can directly damage vascular tissue by producing large amounts of reactive oxygen species (ROS). Oxidative stress leads to the disorder of liver lipid metabolism, which is also an important mechanism leading to cirrhosis and liver fibrosis. However, the influence of cyanate on liver has remained unclear. In this research, we explored the effects of cyanate on the oxidative stress injury and abnormal lipid metabolism in mice and HL-7702 cells. In results, cyanate induced hyperlipidemia and oxidative stress by influencing the content of total cholesterol (TC), high-density lipoprotein (HDL), low-density lipoprotein (LDL), superoxide dismutase (SOD), catalase (CAT) in liver. Cyanate inhibited NF-E2-related factor 2 (Nrf2), heme oxygenase-1 (HO-1), and the phosphorylation of adenosine 5\u2032monophosphate-activated protein kinase (AMPK), activated the mTOR pathway. Oxidative stress on the cells reduced significantly by treating with TBHQ, an antioxidant, which is also an activator of Nrf2. The activity of Nrf2 was rehabilitated and phosphorylation of mTOR decreased. In conclusion, cyanate could induce oxidative stress damage and lipid deposition by inhibiting Nrf2\/HO-1 pathway, which was rescued by inhibitor of Nrf2.<\/jats:p>","DOI":"10.3390\/molecules24183231","type":"journal-article","created":{"date-parts":[[2019,9,6]],"date-time":"2019-09-06T02:59:22Z","timestamp":1567738762000},"page":"3231","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":53,"title":["Cyanate Induces Oxidative Stress Injury and Abnormal Lipid Metabolism in Liver through Nrf2\/HO-1"],"prefix":"10.3390","volume":"24","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1143-1458","authenticated-orcid":false,"given":"Ling","family":"Hu","sequence":"first","affiliation":[{"name":"Neuroscience Research Center, College of Basic Medicine, Chongqing Medical University, Chongqing 400016, China"},{"name":"Lab of Stem Cell and Tissue Engineering, Department of Histology and Embryology, Chongqing Medical University, Chongqing 400016, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kuan","family":"Tian","sequence":"additional","affiliation":[{"name":"Neuroscience Research Center, College of Basic Medicine, Chongqing Medical University, Chongqing 400016, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tao","family":"Zhang","sequence":"additional","affiliation":[{"name":"Neuroscience Research Center, College of Basic Medicine, Chongqing Medical University, Chongqing 400016, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chun-Hua","family":"Fan","sequence":"additional","affiliation":[{"name":"Neuroscience Research Center, College of Basic Medicine, Chongqing Medical University, Chongqing 400016, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peng","family":"Zhou","sequence":"additional","affiliation":[{"name":"Lab of Stem Cell and Tissue Engineering, Department of Histology and Embryology, Chongqing Medical University, Chongqing 400016, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Di","family":"Zeng","sequence":"additional","affiliation":[{"name":"Lab of Stem Cell and Tissue Engineering, Department of Histology and Embryology, Chongqing Medical University, Chongqing 400016, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuang","family":"Zhao","sequence":"additional","affiliation":[{"name":"Lab of Stem Cell and Tissue Engineering, Department of Histology and Embryology, Chongqing Medical University, Chongqing 400016, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li-Sha","family":"Li","sequence":"additional","affiliation":[{"name":"Lab of Stem Cell and Tissue Engineering, Department of Histology and Embryology, Chongqing Medical University, Chongqing 400016, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hendrea Shaniqua","family":"Smith","sequence":"additional","affiliation":[{"name":"Neuroscience Research Center, College of Basic Medicine, Chongqing Medical University, Chongqing 400016, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Li","sequence":"additional","affiliation":[{"name":"Lab of Stem Cell and Tissue Engineering, Department of Histology and Embryology, Chongqing Medical University, Chongqing 400016, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jian-Hua","family":"Ran","sequence":"additional","affiliation":[{"name":"Neuroscience Research Center, College of Basic Medicine, Chongqing Medical University, Chongqing 400016, China"},{"name":"Lab of Stem Cell and Tissue Engineering, Department of Histology and Embryology, Chongqing Medical University, Chongqing 400016, China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2019,9,5]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"1238","DOI":"10.1016\/S0140-6736(16)32064-5","article-title":"Chronic Kidney Disease","volume":"389","author":"Webster","year":"2017","journal-title":"Lancet"},{"key":"ref_2","doi-asserted-by":"crossref","unstructured":"(2017). Erratum: Kidney Disease: Improving Global Outcomes (KDIGO) CKD-MBD Update Work Group. KDIGO 2017 Clinical Practice Guideline Update for the Diagnosis, Evaluation, Prevention, and Treatment of Chronic Kidney Disease-Mineral and Bone Disorder (CKD-MBD). Kidney Int. Suppl., 7, 1\u201359.","DOI":"10.1016\/j.kisu.2017.04.001"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1159\/000485823","article-title":"Preface\u2014Advances in CKD 2018","volume":"45","author":"Kotanko","year":"2018","journal-title":"Blood Purif."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1053\/j.ajkd.2014.07.033","article-title":"Effective CKD care in European countries: Challenges and opportunities for health policy","volume":"65","author":"Bello","year":"2015","journal-title":"Am. J. Kidney Dis. Off. J. Natl. Kidney Found."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1038\/nrneph.2010.59","article-title":"Role of triglyceride-rich lipoproteins in diabetic nephropathy","volume":"6","author":"Rutledge","year":"2010","journal-title":"Nat. Rev. Nephrol."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"713","DOI":"10.2169\/internalmedicine.49.2792","article-title":"Low-density lipoprotein (LDL) cholesterol is cross-sectionally associated with preclinical chronic kidney disease (CKD) in Japanese men","volume":"49","author":"Oda","year":"2010","journal-title":"Intern Med."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1053\/j.ajkd.2006.05.021","article-title":"Cardiovascular outcomes and all-cause mortality: Exploring the interaction between CKD and cardiovascular disease","volume":"48","author":"Weiner","year":"2006","journal-title":"Am. J. Kidney Dis. Off. J. Natl. Kidney Found."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1016\/j.semnephrol.2018.02.002","article-title":"Cardiovascular Risk Prediction in CKD","volume":"38","author":"Ballew","year":"2018","journal-title":"Semin. Nephrol."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1161\/CIRCULATIONAHA.106.678342","article-title":"Chronic kidney disease: Effects on the cardiovascular system","volume":"116","author":"Schiffrin","year":"2007","journal-title":"Circulation"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"381","DOI":"10.7150\/ijms.7069","article-title":"The impact of chronic kidney disease on lipid management and goal attainment in patients with atherosclerosis diseases in Taiwan","volume":"11","author":"Lin","year":"2014","journal-title":"Int. J. Med. Sci."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1053\/j.ajkd.2018.11.010","article-title":"Lipids, Apolipoproteins, and Risk of Atherosclerotic Cardiovascular Disease in Persons With CKD","volume":"73","author":"Bajaj","year":"2019","journal-title":"Am. J. Kidney Dis."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"1255","DOI":"10.1016\/j.metabol.2004.05.001","article-title":"Apolipoprotein A-I, B-100, and B-48 metabolism in subjects with chronic kidney disease, obesity, and the metabolic syndrome","volume":"53","author":"Batista","year":"2004","journal-title":"Metab. Clin. Exp."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"1295","DOI":"10.1161\/01.ATV.0000077477.40824.52","article-title":"Mechanisms of renal structural alterations in combined hypercholesterolemia and renal artery stenosis","volume":"23","author":"Chade","year":"2003","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1093\/clinchem\/42.3.482","article-title":"Plasma cyanate concentrations in chronic renal failure","volume":"42","author":"Nilsson","year":"1996","journal-title":"Clin. Chem."},{"key":"ref_15","first-page":"1474","article-title":"Accumulation of cyanide and thiocyanate in haemodialysis patients","volume":"19","author":"Hasuike","year":"2004","journal-title":"Nephrol. Dial. Transplant. Off. Publ. Eur. Dial. Transpl. Assoc. Eur. Ren. Assoc."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"1176","DOI":"10.1038\/nm1637","article-title":"Protein carbamylation links inflammation, smoking, uremia and atherogenesis","volume":"13","author":"Wang","year":"2007","journal-title":"Nat. Med."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1053\/j.ajkd.2014.04.034","article-title":"Protein carbamylation in kidney disease: Pathogenesis and clinical implications","volume":"64","author":"Kalim","year":"2014","journal-title":"Am. J. Kidney Dis. Off. J. Natl. Kidney Found."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1038\/ki.2015.166","article-title":"Protein carbamylation and cardiovascular disease","volume":"88","author":"Verbrugge","year":"2015","journal-title":"Kidney Int."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"1664","DOI":"10.1016\/j.jacc.2016.07.755","article-title":"Carbamylated Low-Density Lipoproteins Induce a Prothrombotic State Via LOX-1, Impact on Arterial Thrombus Formation In Vivo","volume":"68","author":"Holy","year":"2016","journal-title":"J. Am. Coll. Cardiol."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1172\/JCI37672","article-title":"Urea-induced ROS generation causes insulin resistance in mice with chronic renal failure","volume":"120","author":"Holy","year":"2010","journal-title":"J. Clin. Investig."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1097\/00041552-200311000-00004","article-title":"Oxidative stress in uremia","volume":"12","author":"Himmelfarb","year":"2003","journal-title":"Curr. Opin. Nephrol. Hypertens."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1097\/00041552-200401000-00013","article-title":"Roles of oxidative stress and antioxidant therapy in chronic kidney disease and hypertension","volume":"13","author":"Vaziri","year":"2004","journal-title":"Curr. Opin. Nephrol. Hypertens."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1007\/5584_2015_161","article-title":"Biochemistry of Oxidative Stress","volume":"878","author":"Pruchniak","year":"2016","journal-title":"Adv. Exp. Med. Biol."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1007\/BF01959411","article-title":"Oxidative stress. Biochemistry and human disease","volume":"11","author":"Bast","year":"1989","journal-title":"Pharm. Weekbl. Sci."},{"key":"ref_25","doi-asserted-by":"crossref","unstructured":"Zhou, T., Prather, E.R., Garrison, D.E., and Zuo, L. (2018). Interplay between ROS and Antioxidants during Ischemia-Reperfusion Injuries in Cardiac and Skeletal Muscle. Int. J. Mol. Sci., 19.","DOI":"10.3390\/ijms19020417"},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"1657","DOI":"10.1016\/j.archoralbio.2012.04.021","article-title":"Bioactive polyphenol antioxidants protect oral fibroblasts from ROS-inducing agents","volume":"57","author":"Opperman","year":"2012","journal-title":"Arch. Oral Biol."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"956792","DOI":"10.1155\/2013\/956792","article-title":"Achieving the balance between ROS and antioxidants: When to use the synthetic antioxidants","volume":"2013","author":"Poljsak","year":"2013","journal-title":"Oxid. Med. Cell. Longev."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1016\/j.bbrc.2010.02.071","article-title":"Antioxidants: Molecules, medicines, and myths","volume":"393","author":"Gutteridge","year":"2010","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"ref_29","first-page":"CD008176","article-title":"Antioxidants for chronic kidney disease","volume":"10","author":"Jun","year":"2012","journal-title":"Cochrane Database Syst. Rev."},{"key":"ref_30","first-page":"767","article-title":"Effect of regulating intracellular ROS with antioxidants on the ex vivo expansion of cord blood CD34+ cells","volume":"24","author":"Fan","year":"2008","journal-title":"Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi"},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.intimp.2016.04.007","article-title":"Activation of the NRF2-ARE signalling pathway by the Lentinula edodes polysaccharose LNT alleviates ROS-mediated cisplatin nephrotoxicity","volume":"36","author":"Chen","year":"2016","journal-title":"Int. Immunopharmacol."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1146\/annurev-pharmtox-010818-021856","article-title":"Modulating NRF2 in Disease: Timing Is Everything","volume":"59","author":"Dodson","year":"2019","journal-title":"Annu. Rev. Pharmacol. Toxicol."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.preteyeres.2017.08.003","article-title":"Age-related cataracts: Role of unfolded protein response, Ca mobilization, epigenetic DNA modifications, and loss of Nrf2\/Keap1 dependent cytoprotection","volume":"60","author":"Periyasamy","year":"2017","journal-title":"Prog. Retin. Eye Res."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"1664","DOI":"10.1080\/15548627.2017.1345411","article-title":"N-3 PUFAs induce inflammatory tolerance by formation of KEAP1-containing SQSTM1\/p62-bodies and activation of NFE2L2","volume":"13","author":"Mildenberger","year":"2017","journal-title":"Autophagy"},{"key":"ref_35","doi-asserted-by":"crossref","unstructured":"Tsakiri, E.N., Gumeni, S., Vougas, K., Pendin, D., Papassideri, I., Daga, A., Gorgoulis, V., Juh\u00e1sz, G., Scorrano, L., and Trougakos, I.P. (2019). Proteasome dysfunction induces excessive proteome instability and loss of mitostasis that can be mitigated by enhancing mitochondrial fusion or autophagy. Autophagy.","DOI":"10.1080\/15548627.2019.1596477"},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"eaav4570","DOI":"10.1126\/sciadv.aav4570","article-title":"The protein kinase activity of fructokinase A specifies the antioxidant responses of tumor cells by phosphorylating p62","volume":"5","author":"Xu","year":"2019","journal-title":"Sci. Adv."},{"key":"ref_37","doi-asserted-by":"crossref","unstructured":"Shanmugam, G., Challa, A.K., Litovsky, S.H., Devarajan, A., Wang, D., Jones, D.P., Darley-Usmar, V.M., and Rajasekaran, N.S. (2019). Enhanced Keap1-Nrf2 signaling protects the myocardium from isoproterenol-induced pathological remodeling in mice. Redox Biol.","DOI":"10.1016\/j.redox.2019.101212"},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1080\/07315724.2014.1003419","article-title":"Simultaneous Activation of Nrf2 and Elevation of Dietary and Endogenous Antioxidant Chemicals for Cancer Prevention in Humans","volume":"35","author":"Prasad","year":"2016","journal-title":"J. Am. Coll. Nutr."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/j.fct.2018.03.029","article-title":"l-Arginine induces antioxidant response to prevent oxidative stress via stimulation of glutathione synthesis and activation of Nrf2 pathway","volume":"115","author":"Liang","year":"2018","journal-title":"Food Chem. Toxicol. Int. J. Publ. Br. Ind. Biol. Res. Assoc."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"1864","DOI":"10.1001\/jama.2017.4046","article-title":"Assessment of Global Kidney Health Care Status","volume":"317","author":"Bello","year":"2017","journal-title":"JAMA"},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1038\/ki.2009.157","article-title":"Transcription factor Nrf2 is protective during ischemic and nephrotoxic acute kidney injury in mice","volume":"76","author":"Liu","year":"2009","journal-title":"Kidney Int."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1038\/nrneph.2010.36","article-title":"HDL metabolism and activity in chronic kidney disease","volume":"6","author":"Vaziri","year":"2010","journal-title":"Nat. Rev. Nephrol."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1038\/nrneph.2017.51","article-title":"The immunology of atherosclerosis","volume":"13","author":"Hansson","year":"2017","journal-title":"Nat. Rev. Nephrol."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"1433","DOI":"10.1016\/j.bbadis.2014.04.026","article-title":"Cardiac remodeling associated with protein increase and lipid accumulation in early-stage chronic kidney disease in rats","volume":"1842","author":"Kuwahara","year":"2014","journal-title":"Biochim. Biophys. Acta"},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1038\/nrneph.2017.155","article-title":"Dyslipidaemia in nephrotic syndrome: Mechanisms and treatment","volume":"14","author":"Agrawal","year":"2018","journal-title":"Nat. Rev. Nephrol."},{"key":"ref_46","doi-asserted-by":"crossref","unstructured":"Khatiwada, S., Rajendra, K.C., Gautam, S., Lamsal, M., and Baral, N. (2015). Thyroid dysfunction and dyslipidemia in chronic kidney disease patients. BMC Endocr. Disord., 15.","DOI":"10.1186\/s12902-015-0063-9"},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"54","DOI":"10.3810\/pgm.2009.11.2077","article-title":"Dyslipidemia in chronic kidney disease: Managing a high-risk combination","volume":"121","author":"Chauhan","year":"2009","journal-title":"Postgrad. Med."},{"key":"ref_48","first-page":"305","article-title":"Plasma lipoprotein abnormalities in hemodialysis patients\u2014Clinical implications and therapeutic guidelines","volume":"10","author":"Shoji","year":"2006","journal-title":"Ther. Apher. Dial. Off. Peer-Rev. J. Int. Soc. Apher. Jpn. Soc. Apher. Jpn. Soc. Dial. Ther."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"S226","DOI":"10.1681\/ASN.2006080919","article-title":"Lipid changes and statins in chronic renal insufficiency","volume":"17","author":"Ritz","year":"2006","journal-title":"J. Am. Soc. Nephrol. JASN"},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1161\/HYPERTENSIONAHA.112.198770","article-title":"CD36 and Na\/K-ATPase-\u03b11 form a proinflammatory signaling loop in kidney","volume":"61","author":"Kennedy","year":"2013","journal-title":"Hypertension"},{"key":"ref_51","doi-asserted-by":"crossref","unstructured":"Gai, Z., Wang, T., Visentin, M., Kullak-Ublick, G.A., Fu, X., and Wang, Z. (2019). Lipid Accumulation and Chronic Kidney Disease. Nutrients, 11.","DOI":"10.3390\/nu11040722"},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1053\/j.ajkd.2015.06.028","article-title":"Cholesterol Metabolism in CKD","volume":"66","author":"Reiss","year":"2015","journal-title":"Am. J. Kidney Dis. Off. J. Natl. Kidney Found."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/j.cbi.2017.10.026","article-title":"Cyanate improves insulin sensitivity and hepatic steatosis in normal and high fat-fed mice: Anorexic and antioxidative effects","volume":"279","author":"Kang","year":"2018","journal-title":"Chem. Biol. Interact."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"R26","DOI":"10.1152\/ajpregu.00049.2014","article-title":"Oxidative stress and altered lipid homeostasis in the programming of offspring fatty liver by maternal obesity","volume":"307","author":"Alfaradhi","year":"2014","journal-title":"Am. J. Physiol. Regul. Integr. Comp. Physiol."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"473","DOI":"10.3109\/15376516.2011.556155","article-title":"The effect of the uremic toxin cyanate (CNO\u207b) on anaerobic cysteine metabolism and oxidative processes in the rat liver: A protective effect of lipoate","volume":"21","author":"Niedzielska","year":"2011","journal-title":"Toxicol. Mech. Methods"},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1111\/j.1525-139X.2010.00819.x","article-title":"What we know about oxidative stress in patients with chronic kidney disease on dialysis\u2014Clinical effects, potential treatment, and prevention","volume":"24","author":"Locatelli","year":"2011","journal-title":"Semin. Dial."},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"752","DOI":"10.1053\/j.ajkd.2006.08.015","article-title":"Oxidative stress is progressively enhanced with advancing stages of CKD","volume":"48","author":"Dounousi","year":"2006","journal-title":"Am. J. Kidney Dis. Off. J. Natl. Kidney Found."},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.1111\/j.1523-1755.2004.00465.x","article-title":"Increased prevalence of oxidant stress and inflammation in patients with moderate to severe chronic kidney disease","volume":"65","author":"Oberg","year":"2004","journal-title":"Kidney Int."},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1038\/ki.2012.439","article-title":"Targeting the transcription factor Nrf2 to ameliorate oxidative stress and inflammation in chronic kidney disease","volume":"83","author":"Ruiz","year":"2013","journal-title":"Kidney Int."},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"992","DOI":"10.1161\/01.CIR.0000050628.11305.30","article-title":"The antioxidant acetylcysteine reduces cardiovascular events in patients with end-stage renal failure: A randomized, controlled trial","volume":"107","author":"Tepel","year":"2003","journal-title":"Circulation"},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"1282","DOI":"10.1016\/j.kint.2017.05.015","article-title":"Real-time in vivo mitochondrial redox assessment confirms enhanced mitochondrial reactive oxygen species in diabetic nephropathy","volume":"92","author":"Galvan","year":"2017","journal-title":"Kidney Int."},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"F423","DOI":"10.1152\/ajprenal.00321.2017","article-title":"Role of mitochondria-derived reactive oxygen species in microvascular dysfunction in chronic kidney disease","volume":"314","author":"Kirkman","year":"2018","journal-title":"Am. J. Physiol. Ren. Physiol."},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"F63","DOI":"10.1152\/ajprenal.2000.278.1.F63","article-title":"Oxidant stress in hyperlipidemia-induced renal damage","volume":"278","author":"Scheuer","year":"2000","journal-title":"Am. J. Physiol. Ren. Physiol."},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"1169","DOI":"10.1152\/physrev.00023.2017","article-title":"The KEAP1-NRF2 System: A Thiol-Based Sensor-Effector Apparatus for Maintaining Redox Homeostasis","volume":"98","author":"Yamamoto","year":"2018","journal-title":"Physiol. Rev."},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"2809","DOI":"10.2337\/db06-1003","article-title":"Activation of NF-E2-related factor-2 reverses biochemical dysfunction of endothelial cells induced by hyperglycemia linked to vascular disease","volume":"57","author":"Xue","year":"2008","journal-title":"Diabetes"},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1038\/s41573-018-0008-x","article-title":"Therapeutic targeting of the NRF2 and KEAP1 partnership in chronic diseases","volume":"18","author":"Cuadrado","year":"2019","journal-title":"Nat. Rev. Drug Discov."},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1038\/s41586-018-0622-0","article-title":"A metabolite-derived protein modification integrates glycolysis with KEAP1-NRF2 signalling","volume":"562","author":"Bollong","year":"2018","journal-title":"Nature"},{"key":"ref_68","doi-asserted-by":"crossref","unstructured":"Li, Y., Shi, J., Sun, X., Li, Y., Duan, Y., and Yao, H. (2019). Theaflavic acid from black tea protects PC12 cells against ROS-mediated mitochondrial apoptosis induced by OGD\/R via activating Nrf2\/ARE signaling pathway. J. Nat. Med.","DOI":"10.1007\/s11418-019-01333-4"},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"11227","DOI":"10.1002\/jcp.27773","article-title":"Biogenic nanoselenium particles activate Nrf2-ARE pathway by phosphorylating p38, ERK1\/2, and AKT on IPEC-J2 cells","volume":"234","author":"Xiao","year":"2019","journal-title":"J. Cell. Physiol."},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/j.atherosclerosis.2019.02.010","article-title":"Z-Ligustilide protects vascular endothelial cells from oxidative stress and rescues high fat diet-induced atherosclerosis by activating multiple NRF2 downstream genes","volume":"284","author":"Zhu","year":"2019","journal-title":"Atherosclerosis"},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"28351","DOI":"10.18632\/oncotarget.25322","article-title":"Increased Nrf2 expression by renal cell carcinoma is associated with postoperative chronic kidney disease and an unfavorable prognosis","volume":"9","author":"Yuki","year":"2018","journal-title":"Oncotarget"},{"key":"ref_72","doi-asserted-by":"crossref","unstructured":"Hishikawa, A., Hayashi, K., and Itoh, H. (2018). Transcription Factors as Therapeutic Targets in Chronic Kidney Disease. Molecules, 23.","DOI":"10.3390\/molecules23051123"},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"4063","DOI":"10.1111\/jcmm.14293","article-title":"Aucubin inhibited lipid accumulation and oxidative stress via Nrf2\/HO-1 and AMPK signalling pathways","volume":"23","author":"Shen","year":"2019","journal-title":"J. Cell. Mol. Med."},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"13599","DOI":"10.1093\/nar\/gku1169","article-title":"Non-coding RNA derived from the region adjacent to the human HO-1 E2 enhancer selectively regulates HO-1 gene induction by modulating Pol II binding","volume":"42","author":"Maruyama","year":"2014","journal-title":"Nucleic Acids Res."},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1007\/s00011-019-01241-z","article-title":"Chicoric acid prevents methotrexate-induced kidney injury by suppressing NF-kappaB\/NLRP3 inflammasome activation and up-regulating Nrf2\/ARE\/HO-1 signaling","volume":"68","author":"Hussein","year":"2019","journal-title":"Inflamm. Res."},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/j.phrs.2018.06.013","article-title":"Canonical and non-canonical mechanisms of Nrf2 activation","volume":"134","author":"Maldonado","year":"2018","journal-title":"Pharmacol. Res."},{"key":"ref_77","doi-asserted-by":"crossref","unstructured":"Kneeshaw, S., Keyani, R., Delorme-Hinoux, V., Imrie, L., Loake, G.J., Le Bihan, T., Reichheld, J.P., and Spoel, S.H. (2017). Nucleoredoxin guards against oxidative stress by protecting antioxidant enzymes. Proc. Natl. Acad. Sci. USA.","DOI":"10.1073\/pnas.1703344114"},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1016\/j.redox.2017.03.001","article-title":"Xanthohumol ameliorates lipopolysaccharide (LPS)-induced acute lung injury via induction of AMPK\/GSK3\u03b2-Nrf2 signal axis","volume":"12","author":"Lv","year":"2017","journal-title":"Redox Biol."},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"875961","DOI":"10.1155\/2015\/875961","article-title":"New Insights for Oxidative Stress and Diabetes Mellitus","volume":"2015","author":"Maiese","year":"2015","journal-title":"Oxidative Med. Cell. Longev."},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1186\/s13578-016-0099-1","article-title":"Hydrogen sulfide decreases high glucose\/palmitate-induced autophagy in endothelial cells by the Nrf2-ROS-AMPK signaling pathway","volume":"6","author":"Liu","year":"2016","journal-title":"Cell Biosci."},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"S10","DOI":"10.1161\/CIRCULATIONAHA.108.828426","article-title":"Reactive oxygen species-induced stimulation of 5\u2032AMP-activated protein kinase mediates sevoflurane-induced cardioprotection","volume":"120","author":"Lamberts","year":"2009","journal-title":"Circulation"},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1186\/s12943-015-0379-0","article-title":"NOX1 to NOX2 switch deactivates AMPK and induces invasive phenotype in colon cancer cells through overexpression of MMP-7","volume":"14","author":"Banskota","year":"2015","journal-title":"Mol. Cancer"},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1016\/j.cell.2012.03.017","article-title":"mTOR signaling in growth control and disease","volume":"149","author":"Laplante","year":"2012","journal-title":"Cell"},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"67","DOI":"10.4103\/0019-5154.123499","article-title":"mTOR Signaling Cascade in Psoriatic Disease: Double Kinase mTOR Inhibitor a Novel Therapeutic Target","volume":"59","author":"Raychaudhuri","year":"2014","journal-title":"Indian J. Dermatol."},{"key":"ref_85","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1016\/j.ceb.2011.09.003","article-title":"mTOR signaling in disease","volume":"23","author":"Dazert","year":"2011","journal-title":"Curr. Opin. Cell Biol."},{"key":"ref_86","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.ceb.2017.01.005","article-title":"AMPK signalling in health and disease","volume":"45","author":"Carling","year":"2017","journal-title":"Curr. Opin. Cell Biol."},{"key":"ref_87","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1042\/BJ20082055","article-title":"AMPK and the biochemistry of exercise: Implications for human health and disease","volume":"418","author":"Richter","year":"2009","journal-title":"Biochem. J."},{"key":"ref_88","doi-asserted-by":"crossref","first-page":"276","DOI":"10.3109\/10409238.2010.488215","article-title":"AMPK inhibition in health and disease","volume":"45","author":"Viollet","year":"2010","journal-title":"Crit. Rev. Biochem. Mol. Biol."},{"key":"ref_89","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1016\/j.molcel.2008.03.003","article-title":"AMPK phosphorylation of raptor mediates a metabolic checkpoint","volume":"30","author":"Gwinn","year":"2008","journal-title":"Mol. Cell"},{"key":"ref_90","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1016\/S0092-8674(03)00929-2","article-title":"TSC2 mediates cellular energy response to control cell growth and survival","volume":"115","author":"Inoki","year":"2003","journal-title":"Cell"}],"container-title":["Molecules"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1420-3049\/24\/18\/3231\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T13:17:08Z","timestamp":1760188628000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1420-3049\/24\/18\/3231"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,9,5]]},"references-count":90,"journal-issue":{"issue":"18","published-online":{"date-parts":[[2019,9]]}},"alternative-id":["molecules24183231"],"URL":"https:\/\/doi.org\/10.3390\/molecules24183231","relation":{},"ISSN":["1420-3049"],"issn-type":[{"value":"1420-3049","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,9,5]]}}}